Tal Teitz

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Tyrosine Kinase

High Fat Diet Induced

Top Venues

The Journal of neuroscience : the official journal of the Society for Neuroscience

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Richard D Lutze, Matthew A Ingersoll, Regina G Kelmann, Tal Teitz
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Richard D Lutze, Matthew A Ingersoll, Regina G Kelmann, Tal Teitz
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Richard D Lutze, Matthew A Ingersoll, Alena Thotam, Anjali Joseph, Joshua Fernandes, Tal Teitz
ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response. International journal of molecular sciences 25 (12) (2024)
Matthew A Ingersoll, Richard D Lutze, Regina G Kelmann, Daniel F Kresock, Jordan D Marsh, Rene V Quevedo, Jian Zuo, Tal Teitz
KSR1 Knockout Mouse Model Demonstrates MAPK Pathway's Key Role in Cisplatin- and Noise-induced Hearing Loss. The Journal of neuroscience : the official journal of the Society for Neuroscience 44 (18) (2024)
Emma J Sailor-Longsworth, Richard D Lutze, Matthew A Ingersoll, Regina G Kelmann, Kristina Ly, Duane Currier, Taosheng Chen, Jian Zuo, Tal Teitz
Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice. Clinical and translational medicine 14 (8) (2024)
Richard D Lutze, Matthew A Ingersoll, Regina G Kelmann, Tal Teitz
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Emma J Sailor-Longsworth, Richard D Lutze, Matthew A Ingersoll, Regina G Kelmann, Kristina Ly, Duane Currier, Taosheng Chen, Jian Zuo, Tal Teitz
Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice. Clinical and translational medicine 14 (8) (2024)
Matthew A Ingersoll, Richard D Lutze, Regina G Kelmann, Daniel F Kresock, Jordan D Marsh, Rene V Quevedo, Jian Zuo, Tal Teitz
KSR1 Knockout Mouse Model Demonstrates MAPK Pathway's Key Role in Cisplatin- and Noise-induced Hearing Loss. The Journal of neuroscience : the official journal of the Society for Neuroscience 44 (18) (2024)
Richard D Lutze, Matthew A Ingersoll, Alena Thotam, Anjali Joseph, Joshua Fernandes, Tal Teitz
ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response. International journal of molecular sciences 25 (12) (2024)
Richard D Lutze, Matthew A Ingersoll, Alena Thotam, Anjali Joseph, Joshua Fernandes, Tal Teitz
ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response. International journal of molecular sciences 25 (12) (2024)
Richard D Lutze, Matthew A Ingersoll, Alena Thotam, Anjali Joseph, Joshua Fernandes, Tal Teitz
ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response. International journal of molecular sciences 25 (12) (2024)
Matthew A Ingersoll, Richard D Lutze, Regina G Kelmann, Daniel F Kresock, Jordan D Marsh, Rene V Quevedo, Jian Zuo, Tal Teitz
KSR1 Knockout Mouse Model Demonstrates MAPK Pathway's Key Role in Cisplatin- and Noise-induced Hearing Loss. The Journal of neuroscience : the official journal of the Society for Neuroscience 44 (18) (2024)
Emma J Sailor-Longsworth, Richard D Lutze, Matthew A Ingersoll, Regina G Kelmann, Kristina Ly, Duane Currier, Taosheng Chen, Jian Zuo, Tal Teitz
Oseltamivir (Tamiflu), a commonly prescribed antiviral drug, mitigates hearing loss in mice. Clinical and translational medicine 14 (8) (2024)
Richard D Lutze, Matthew A Ingersoll, Regina G Kelmann, Tal Teitz
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Matthew A Ingersoll, Richard D Lutze, Regina G Kelmann, Daniel F Kresock, Jordan D Marsh, Rene V Quevedo, Jian Zuo, Tal Teitz
KSR1 Knockout Mouse Model Demonstrates MAPK Pathway's Key Role in Cisplatin- and Noise-induced Hearing Loss. The Journal of neuroscience : the official journal of the Society for Neuroscience 44 (18) (2024)
Richard D Lutze, Matthew A Ingersoll, Alena Thotam, Anjali Joseph, Joshua Fernandes, Tal Teitz
ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response. bioRxiv : the preprint server for biology (2023)
Chithra K Pushpan, Daniel F Kresock, Matthew A Ingersoll, Richard D Lutze, Darby L Keirns, William J Hunter, Khalid Bashir, Tal Teitz
Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced Acute Kidney Injury. Journal of the American Society of Nephrology : JASN (2023)
Matthew A Ingersoll, Emma A Malloy, Lauryn E Caster, Eva M Holland, Zhenhang Xu, Marisa Zallocchi, Duane Currier, Huizhan Liu, David Z Z He, Jaeki Min, Taosheng Chen, Jian Zuo, Tal Teitz
BRAF inhibition protects against hearing loss in mice. Science advances 6 (49) (2020)